Incyte
INCY
#1201
Rank
C$27.90 B
Marketcap
C$139.66
Share price
-2.19%
Change (1 day)
43.31%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2026 (TTM): C$10.06

According to Incyte's latest financial reports the company's current EPS (TTM) is C$10.22. In 2025 the company made an earnings per share (EPS) of C$9.24 an increase over its 2024 EPS that were of C$0.43.

EPS history for Incyte from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$10.068.86%
2025C$9.242029.03%
2024C$0.43-88.39%
2023C$3.7473.38%
2022C$2.16-64.1%
2021C$6.01-408.63%
2020C-$1.95-166.83%
2019C$2.91300%
2018C$0.73-133.33%
2017C-$2.18-378.57%
2016C$0.782700%
2015C$0.02800-106.67%
2014C-$0.42-44.44%
2013C-$0.7650%
2012C-$0.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
C$9.83-3.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.83-82.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$39.52 286.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$20.27 98.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$8.82-13.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
C-$0.18-101.78%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
C-$0.81-107.95%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
C-$1.18-111.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
C-$0.32-103.15%๐Ÿ‡บ๐Ÿ‡ธ USA